Global Bio-chem Technology Group Company Limited

DB:GLY Stock Report

Market Cap: €72.6m

Global Bio-chem Technology Group Balance Sheet Health

Financial Health criteria checks 0/6

Global Bio-chem Technology Group has a total shareholder equity of HK$-2.7B and total debt of HK$3.9B, which brings its debt-to-equity ratio to -143.6%. Its total assets and total liabilities are HK$4.9B and HK$7.6B respectively.

Key information

-143.6%

Debt to equity ratio

HK$3.87b

Debt

Interest coverage ration/a
CashHK$125.48m
Equity-HK$2.70b
Total liabilitiesHK$7.56b
Total assetsHK$4.86b

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: GLY has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: GLY has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: GLY has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: GLY's has negative shareholder equity, so we do not need to check if its debt has reduced over time.

Debt Coverage: GLY's debt is not well covered by operating cash flow (2.9%).

Interest Coverage: Insufficient data to determine if GLY's interest payments on its debt are well covered by EBIT.


Balance Sheet


Discover healthy companies